All In MedTech

Device Trial Radar · NCT01597063

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy

Last checked: Nov 19, 2026Latest source record: Apr 20, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

3,333

Actual

Start

Jul 2012

Primary completion

Feb 2014

Study completion Dec 2015

Sponsor

Lead sponsor
Sequenom, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 11, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
Female only, from 18 years, up to 34 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pregnant women with low risk indicators for fetal chromosomal aneuploidy will be enrolled. Study blood will be collected in the first or second trimester at a scheduled prenatal screening visit, processed to plasma, and stored frozen until analysis. Each pregnancy will be followed until delivery and the birth outcome recorded.

Conditions

  • Aneuploidy
  • Down Syndrome
  • Noninvasive Prenatal Screening

Interventions

  • SEQureDx Trisomy TestDevice

    Plasma samples obtained from maternal blood will be tested using the SEQureDx Trisomy Test, an in vitro diagnostic test that measures circulating cell-free fetal DNA. The test detects the relative quantity of chromosome 21, which is associated with trisomy 21.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Estimate the false positive rate of SEQureDx Trisomy 21 TestTime frame: pregnancy outcome

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • University of South Alabama

    Mobile, Alabama

  • New Horizon Women's Care

    Chandler, Arizona

  • Precision Trials

    Phoenix, Arizona

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.